Reply to: machine learning in renal cell carcinoma research: promise and pitfalls of ‘renal‐izing’ the potential of artificial intelligence
BJU International · 2023
DOI: 10.1111/bju.16116 ↗Kurz gefasst
Leserbrief in der Zeitschrift BJU International, 2023. Verfasst von Astrid Boulenger de Hauteclocque und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre Hospitalier Universitaire de Bordeaux Groupe Hospitalier Pellegrin, Bordeaux, France. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Centre Hospitalier Universitaire de Bordeaux Groupe Hospitalier Pellegrin, Bordeaux, France.
- SOPHiA GENETICS SAS, Bidart, France.
ORCID-Profile: Astrid Boulenger de Hauteclocque, Gaëlle Margue
Zitieren
APA
Boulenger de Hauteclocque, A., Ferrer, L., Margue, G., Etchepare, G., Colin, T., & Bernhard, J. C. (2023). Reply to: machine learning in renal cell carcinoma research: promise and pitfalls of ‘renal‐izing’ the potential of artificial intelligence. BJU International. https://doi.org/10.1111/bju.16116
Vancouver
Boulenger de Hauteclocque A, Ferrer L, Margue G, Etchepare G, Colin T, Bernhard JC. Reply to: machine learning in renal cell carcinoma research: promise and pitfalls of ‘renal‐izing’ the potential of artificial intelligence. BJU International. 2023. doi:10.1111/bju.16116
BibTeX
@article{BoulengerdeHauteclocque2023,
author = {Boulenger de Hauteclocque, Astrid and Ferrer, Loïc and Margue, Gaëlle and Etchepare, Guillaume and Colin, Thierry and Bernhard, Jean-Christophe},
title = {Reply to: machine learning in renal cell carcinoma research: promise and pitfalls of ‘renal‐izing’ the potential of artificial intelligence},
journal = {BJU International},
year = {2023},
doi = {10.1111/bju.16116}
}
EUVIMED